how is semaglutide metabolized targets MASH molecular pathways beyond weight loss Why Am I Not Losing

This suggests weight loss alone may not fully explain the observed benefits of semaglutide and that other factors may also be at play, e.g., potential anti-inflammatory effects

However, these outcomes are gradual and best measured over several months not weeks

Gradually discontinue 15 mg/92 mg dosage to prevent possible seizure ( 2.3)

Firstly, subcutaneous semaglutide has already been proven to be superior to placebo in reducing cardiovascular risk, while the data on oral semaglutides cardiovascular benefits wont be available until 2024

By integrating network pharmacology, MR analysis, and transcriptomic validation, we demonstrate that metformins multimodal actions, spanning metabolic regulation, neuroinflammation, and antiviral defense, may underlie its stronger neuroprotective effects